Impact of zoledronic acid on control of metastatic spinal cord compression.
Related Research units
Abstract
Zoledronic acid was demonstrated to reduce the rate of skeletal-related events, a hypernym including various outcomes, in patients with bone metastases. In contrast to other studies, this matched-pair analysis focused solely on the impact of zoledronic acid on metastatic spinal cord compression (MSCC).
Bibliographical data
| Original language | English |
|---|---|
| Article number | 10 |
| ISSN | 0179-7158 |
| Publication status | Published - 2012 |
| pubmed | 22903395 |
|---|
